Abstracts tagged "Rheumatoid arthritis (RA)"

Abstract Number: 498 • 2018 ACR/ARHP Annual Meeting
Trends in the Incidence of Cardiovascular Diseases in Patients with Rheumatoid Arthritis in Spain: A National Observational Cohort Study of Hospital Discharges
Cristina Macia-Villa¹, Ramon Mazzucchelli², E Perez-Fernandez², Javier Quirós², J.L Morell-Hita³, Natalia Crespí⁴, M Peña², Carmen Barbadillo⁵, Maria Espinosa⁶, Hilda Godoy⁵, Manuel Fernández⁷, María Galindo⁸, Alberto Garcia-Vadillo⁹, O Guzon-Illescas², Angela Herranz¹⁰, Cristina Martinez-Prada¹¹, C Morado-Quiñoa¹¹ and Virginia Villaverde García¹², ¹Hospital Universitario Severo Ochoa, Madrid, Spain, ²H.U.Fundación Alcorcón, Madrid, Spain, ³H.U.Ramón y Cajal, Madrid, Spain, ⁴C.S. La Rivota, Madrid, Spain, ⁵H.U. Puerta de Hierro, Madrid, Spain, ⁶Rheumatology, H.U. Puerta de Hierro, Madrid, Spain, ⁷Hospital Universitario de Guadalajara. Spain, Guadalajara, Spain, ⁸Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, ⁹Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ¹⁰H.U. del Henares, Madrid, Spain, ¹¹H.U. Clínico San Carlos, Madrid, Spain, ¹²Rheumatology, Hospital Universitario de Móstoles, Móstoles, Spain
Background/Purpose: Cardiovascular diseases (CVDs) are a worldwide health problem, with an increased risk in Rheumatoid Arthritis (RA) due to its inflammatory context, comorbidities and the…
Abstract Number: 1199 • 2018 ACR/ARHP Annual Meeting
The Use of Musculoskeletal Ultrasound to Assess Remission in Patients with Rheumatoid Arthritis
Myriam Allen¹, Maggie Larche² and Karen A. Beattie², ¹Rheumatology, McMaster University, Hamilton, ON, Canada, ²Medicine, McMaster University, Hamilton, ON, Canada
Background/Purpose: Patients with rheumatoid arthritis (RA) should achieve remission rapidly to avoid irreversible joint sequela. Studies have shown that patients with apparent clinical remission have…
Abstract Number: 1979 • 2018 ACR/ARHP Annual Meeting
Rheumatoid Arthritis-Associated Genetic Alteration Defines a New Promoter for Peptydil Arginine Deiminase 4 Gene
Daniel M. Tóth¹, Timea Ocskó², Tibor T. Glant¹ and Tibor A. Rauch¹, ¹Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, ²Orthopedic Surgery, Rush University Medical Center, Chicago, IL
Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are frequently detected in Rheumatoid Arthritis (RA) patients and used as diagnostic biomarkers at a very early stage of the…
Abstract Number: 2548 • 2018 ACR/ARHP Annual Meeting
The Impact of Rheumatoid Arthritis on Patient-Reported Outcomes: Comparison between Sarilumab Clinical Trials and Real-World Patient Data
Vibeke Strand¹, Colleen M. Carpinella², Lulu K. Lee², Susan Boklage³ and Matthew Reaney⁴, ¹Stanford University School of Medicine, Palo Alto, CA, ²Kantar Health, San Mateo, CA, ³Regeneron Pharmaceuticals, Inc., Tarrytown, NY, ⁴Sanofi, Guildford, United Kingdom
Background/Purpose: Rheumatoid arthritis (RA) and its treatment have significant impacts on health-related quality of life (HRQoL), work productivity (WP) and activity participation. Data are limited…
Abstract Number: 506 • 2018 ACR/ARHP Annual Meeting
Clinical and Sonographic Characteristics of Carotid Intima-Media Thickness in Rheumatoid Arthritis Patients
José R. Azpiri-López¹, Iris J. Colunga-Pedraza², Estefania E. Abundis-Marquez³, Jose A. Davila-Jimenez³, Andres H. Guillen-Lozoya³, Raymundo Vera-Pineda³, Jesus A. Cardenas-de la Garza³, Adrián Martínez-Moreno³, Rosa I. Arvizu-Rivera³, Francisco J. Torres-Quintanilla³, Aldo Valdovinos-Bañuelos³, Ray Ramos-Cázares³, Cinthia Y. Guillen-Gutierrez³, Guillermo Elizondo-Riojas³, Dionisio Castillo-Ortiz⁴ and Dionicio A. Galarza-Delgado⁵, ¹Cardiology, Hospital Universitario, UANL, Monterrey, Mexico, ²Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico, ³Hospital Universitario, UANL, Monterrey, Mexico, ⁴Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico, ⁵Chief of Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico
Clinical and Sonographic Characteristics of Carotid Intima-media Thickness in Rheumatoid arthritis patientsBackground/Purpose: Rheumatoid arthritis (RA) is a chronic and systemic disease with high cardiovascular (CV)…
Abstract Number: 1203 • 2018 ACR/ARHP Annual Meeting
Tenosynovitis Detected By Ultrasound Predicts Arthritis Onset in Individuals at Risk of Developing Rheumatoid Arthritis
Yogan Kisten¹, Hamed Rezaei¹, Erik af Klint¹, Guozhong Fei^1,2, Aleksandra Antovic^1,2, Aase Hensvold^1,2 and Anca I. Catrina^1,2, ¹Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ²Stockholm Health Services, Academic Specialist Center, Center for Rheumatology, Stockholm, Sweden
Background/Purpose: The urgent need for identifying imaging and serological markers that early predicts rheumatoid arthritis (RA) is clinically important. We aim to identify ultrasound findings…
Abstract Number: 2164 • 2018 ACR/ARHP Annual Meeting
IMPACT of a Systematic Screening of Multimorbidities in Patients with Chronic Inflammatory Rheumatic Diseases
Mégane Beurai-Weber Jr.¹, Audrey Jaussent², Guilhem du Cailar³, Marie-Christine Picot², François Roubille Sr.⁴, Jean-David Cohen⁵, Jacques Morel⁶, Jean Bousquet⁷, Pierre Fesler⁸, Bernard Combe⁹ and Claire Daien¹⁰, ¹Rheumatology Department, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, ²Department of medical information, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, ³Internal Medicine and Hypertension, Hopital Lapeyronie, Montpellier, France, ⁴Department of cardiology, Arnaud de Villeneuve Hospital and Montpellier University, MONTPELLIER, France, ⁵IMMUNO-RHEUMATOLOGY, CHU LAPEYRONIE, MONTPELLIER, France, ⁶Department of Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, ⁷MACVIA-France, Lapeyronie Hospital and Montpellier University, MONTPELLIER, France, ⁸Internal medicine and hypertension, Lapeyronie Hospital and Montpellier University, Montpellier, France, ⁹University Hospital Lapeyronie, Department of Rheumatology, Montpellier, France, ¹⁰Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France
Background/Purpose: EULAR proposes to screen multimorbidities in chronic inflammatory rheumatic diseases. The aim of the study was to assess i) multimorbidities in patients with chronic…
Abstract Number: 2823 • 2018 ACR/ARHP Annual Meeting
Comparative Long-Term Effectiveness of Switching to Another Tumour Necrosis Factor Antagonists, Tocilizumab or Rituximab in Patients with Rheumatoid Arthritis and Inadequate Response to a First-Line TNF Inhibitor
Daniela Santos Faria¹, Mónica Eusébio², Joana Leite Silva³, Joana Ramos Rodrigues¹, Joana Sousa Neves¹, Ana Catarina Duarte⁴, Carina Lopes⁵, Ana Valido⁶, Joana Dinis⁶, João Freitas⁷, Mariana Santiago⁷, Raquel Ferreira⁸, Sara Ganhão⁹, Luís Cunha Miranda¹⁰, Daniela Peixoto¹, Filipa Teixeira¹, Sérgio Alcino¹, Carmo Afonso¹, José Tavares Costa³ and Maria José Santos¹¹, ¹Rheumatology, ULSAM, Ponte de Lima, Portugal, ²Sociedade Portuguesa de Reumatologia, Lisboa, Portugal, LIsboa, Portugal, ³Rheumatology, Unidade Local de Saúde do Alto Minho, Ponte de Lima, Portugal, ⁴Rheumatology, Hospital Garcia de Orta, Almada, Portugal, ⁵Rheumatology, Hospital de Egas Moniz - Centro Hospitalar Lisboa Ocidental, EPE, Lisbon, Portugal, ⁶Rheumatology, Centro Hospitalar Lisboa Norte, Lisbon, Portugal, ⁷Rheumatology, Centro Hospitalar e Universitário de Coimbra, CHUC-EPE, Coimbra, Portugal, ⁸Rheumatology, Centro Hospitalar de São João, Oporto, Portugal, ⁹Rheumatology, Centro Hospitalar de São João, Porto, Portugal, ¹⁰Instituto Português de Reumatologia, Lisbon, Portugal, ¹¹Reuma.pt, Almada, Portugal, Almada, Portugal
Background/Purpose: Tumour necrosis factor inhibitors (TNFi) are highly effective treatments for active Rheumatoid Arthritis (RA). However, up to 40% of patients either fail to respond…
Abstract Number: 516 • 2018 ACR/ARHP Annual Meeting
Microalbuminuria in Rheumatoid Arthritis: Investigating the Association with Diffuse Functional and Morphological Alterations of the Retinal Microvasculature, the Dermal Capillary Network and the Coronary Microcirculation
Panagiota Anyfanti¹, Areti Triantafyllou¹, Eugenia Gkaliagkousi¹, Xenophon Zabulis², Sophia Chatzimichailidou³, Vasiliki Galanopoulou⁴, Stella Douma¹ and Spyros Aslanidis³, ¹3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, Thessaloniki, Greece, ²Institute of Computer Science, Foundation for Research and Technology-Hellas (FORTH), Heraklion, Greece, Heraklion, Greece, ³Rheumatology Department-2nd Propedeutic Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, Thessaloniki, Greece, ⁴Rheumatology Department, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece, Thessaloniki, Greece
Background/Purpose: Increased urinary albumin excretion (UAE) is an early marker of renal microvascular damage that correlates with cardiovascular risk and corresponds to a state of…
Abstract Number: 1225 • 2018 ACR/ARHP Annual Meeting
Screening for Acquired Latent Tuberculosis in Patients with Rheumatoid Arthritis(RA) on Anti-Tnfα Therapy (TNF-I) in Southern California
Noopur Goel¹, Karina Torralba², Lorena Salto¹ and Christina Downey³, ¹Loma Linda University, Loma Linda, CA, ²Division of Rheumatology, Department of Internal Medicine, Loma Linda University, Loma Linda, CA, ³Loma Linda University Medical Center, Loma Linda, CA
Background/Purpose: There is increased risk of tuberculosis in patients treated with TNF-I. ACR guidelines recommend annual screening for latent tuberculosis infection(LTBI) in RA patients with…
Abstract Number: 2209 • 2018 ACR/ARHP Annual Meeting
Fluorescence Optical Imaging Xiralite® Is Helpful in the Decision for Rituximab Re-Therapy in Patients with Rheumatoid Arthritis
Sarah Ohrndorf¹, Lisa Ridha², Anne-Marie Glimm³, Gerd R. Burmester¹, Gabriela Schmittat³, Marina Backhaus⁴ and Jens Klotsche⁵, ¹Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, ²Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, ³Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany, ⁴Department of Rheumatology & Immunology, University Medicine Charit, Berlin, Germany, ⁵Program Area Epidemiology, German Rheumatism Research Center, Berlin, Germany
Background/Purpose: Rituximab (RTX) is an effective and well-tolerated therapeutic option in rheumatoid arthritis (RA) patients with insufficient response to TNFα inhibitors. However, the exact time…
Abstract Number: 2868 • 2018 ACR/ARHP Annual Meeting
Tender Joint Count May Not Reflect Inflammatory Activity in Established Rheumatoid Arthritis Patients; Results from a Longitudinal Study of Tocilizumab
Hilde B Hammer¹, Inger Marie Jensen Hansen², Pentti Järvinen³, Marjatta Leirisalo-Repo⁴, Michael Ziegelasch⁵, Birte Agular⁶ and Lene Terslev⁷, ¹Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Rheumatology, Svendborg Hospital, Svendborg, Denmark, ³Rheumatology, Kiljava Medical Research, Kiljavan, Finland, ⁴Rheumatology, University of Helsinki, Helsinki, Finland, ⁵Rheumatology, University Hospital, Linköping, Linköping, Sweden, ⁶Roche, Copenhagen, Denmark, ⁷Rheumatology, Rigshospitalet Glostrup, Copenhagen, Denmark
Background/Purpose: Tender joints may be caused by non-inflammatory pathologies but are still included in composite scores like CDAI. The present objective was to explore the…
Abstract Number: 530 • 2018 ACR/ARHP Annual Meeting
RA-Voice: Evaluating Laryngeal Involvement in Rheumatoid Arthritis Patients
Ana Águeda¹, Luisa Azevedo², Joaquim Vieira², Sandra Augusto², Catarina Ambrósio¹, Inês Cunha¹ and Anabela Barcelos¹, ¹Rheumatology, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal, ²Otolaryngology, Centro Hospitalar do Baixo Vouga, Aveiro, Portugal
Background/Purpose: Laryngeal involvement is not uncommon in connective tissue diseases including Rheumatoid Arthritis (RA). Its prevalence has been estimated between 5% and 70% of patients…
Abstract Number: 1233 • 2018 ACR/ARHP Annual Meeting
Rituximab Safety in Patients with Rheumatoid Arthritis. an Eleven-Year Follow-up Observational Study
Raul Castellanos-Moreira Sr.¹, Sebastian C Rodriguez-Garcia¹, M. Victoria Hernández², Virginia Ruiz-Esquide³, Oscar Camacho Sr.¹, Andrea Cuervo¹, Julio Ramírez³, Juan Cañete¹, Jose Gomez Puerta¹ and Raimon Sanmarti¹, ¹Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, ²Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ³Rheumatology, Hospital Clínic de Barcelona, Barcelona, Spain
Background/Purpose: Rituximab (RTX) is a chimeric monoclonal antibody approved for the treatment rheumatoid arthritis (RA) patients who failed to respond to tumor necrosis factor inhibitors.…
Abstract Number: 2377 • 2018 ACR/ARHP Annual Meeting
Body Image in Rheumatic Diseases: A Systematic Review
Shadi Gholizadeh¹, Annie Meier², Sarah D. Mills³ and Vanessa L. Malcarne⁴, ¹Clinical Psychology, SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, ²Psychology, San Diego State University, San Diego, CA, ³Medicine, Lineberger Comprehensive Cancer Center University of North Carolina, Durham, NC, ⁴SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA
Background/Purpose: In health conditions that cause changes in appearance, especially in areas of the body that are highly visible and socially salient (e.g., face and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].